Actinium Pharmaceuticals, Inc. (ATNM)
1.26
-0.06
(-4.55%)
USD |
NYAM |
Nov 07, 16:00
1.265
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals EPS Diluted (Quarterly): -0.2205 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcus Biosciences, Inc. | -1.268 |
| Apyx Medical Corp. | -0.0487 |
| AbbVie, Inc. | 0.0993 |
| Karyopharm Therapeutics, Inc. | -3.821 |
| NovaBay Pharmaceuticals, Inc. | -0.3303 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.878M |
| Total Expenses (Quarterly) | 6.878M |
| Enterprise Value | -19.33M |
| Earnings Yield | -104.5% |
| Normalized Earnings Yield | -104.52 |